392
Views
33
CrossRef citations to date
0
Altmetric
REVIEW

Immunosenescence and Immune Response in Organ Transplantation

, &
Pages 162-173 | Accepted 14 Jul 2013, Published online: 15 Oct 2013

REFERENCES

  • Department of Economic and Social Affairs Population Division. World population ageing 1950–2050. United Nations, 2002. pp. 15–22.
  • OPTN home page. Available at: http://optn.transplant.hrsa.gov/data/. Data accessed February 26th of 2013.
  • Pawelec G. Immunosenescence: impact in the young as well as the old? Mech Ageing Dev 1999;108(1):1–7.
  • Castle SC. Clinical relevance of age-related immune dysfunction. Clin Infect Dis 2000;31(2):578–585.
  • Martins PN, Pratschke J, Pascher A, et al. Aging and immune response in organ transplantation. Transplantation 2005;79(2):127–132.
  • Epstein M. Aging and the kidney. J Am Soc Nephrol 1996;7(8):1106–1122.
  • Halloran PF, Melk A, Barth C. Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J Am Soc Nephrol 1999;10(1):167–181.
  • Ginaldi L, De Martinis M, D'Ostilio A, Immunological changes in the elderly. Aging 1999;11(5):281–286.
  • Globerson A, Effros RB. Ageing of lymphocytes and lymphocytes in the aged. Immunol Today 2000;21(10):515–521.
  • Geiger H, Van Zant G. The aging of lympho-hematopoietic stem cells. Nat Immunol 2002;3(4):329–333.
  • Beerman I, Maloney WJ, Weissmann IL, Rossi DJ. Stem cells and the aging hematopoietic system. Curr Opin Immunol 2010a;22(4):500–506.
  • Cossarizza A, Ortolani C, Monti D, Francheschi C. Cytometric analysis of immunosenescence. Cytometry 1997;27(4):297.
  • Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol 2004;5(2):133–139.
  • Lethonen L, Eskola J, Vanio O, Lethonen A. Changes in lymphocyte subsets and immune competence in very advanced age. J Gerontol 1990;45(3):M108–112.
  • Naylor K, Li G, Vallejo AN, The influence of age on T cell generation and TCR diversity. J Immunol 2005;174(11):7446–7452.
  • Uyemura K, Castle SC, Makinodan T. The frail elderly: role of dendritic cells in the susceptibility to infection. Mech Ageing Dev 2002;123(8):955–962.
  • Cossarizza A, Monti D, Cantini M, Extremely low frequency pulsed electromagnetic fields increase interleukin-2 (IL-2) utilization and IL-2 receptor expression in lymphocytes from old subjects. FEBS Lett 1989;248(1–2):141–144.
  • Mo R, Chen J, Han Y, T cell chemokine receptor expression in aging. J Immunol 2003;170(2):895–904.
  • Carson MJ, Sutcliffe JG. Balancing function vs. self defense: the CNS as an active regulator of immune responses. J Neurosci Res 1999;55(1):1–8.
  • Lakkis FG, Sayegh MH. Memory T cells: a hurdle to immunologic tolerance. J Am Soc Nephrol 2003;14(9):2402–2410.
  • Croft M, Bradley LM, Swain SL. Naive versus memory CD4 T cell response to antigen; memory cells are less dependent on accessory cell costimulation and can respond to many APC types including resting B cells. J Immunol 1994;152(6):2675–2685.
  • Dengler TJ, Pober JS. Human vascular endothelial cells stimulate memory but not naive CD8+ T cells to differentiate into CTL retaining an early activation phenotype. J Immunol 2000;164(10):5146–5155.
  • Bingaman AW, Farber DL. Memory T-cells in transplantation: generation, function, and potential role in rejection. Am J Transplant 2004;4(6):846–852.
  • Inbrahim S, Dawson DW, Sanfilippo F. Predominant infiltration of rejecting human renal allografts with T cells expressing CD8 and CD45RO. Transplantation 1995;59:724–728.
  • Kline GH, Hayden TA, Klinman NR. B cell maintenance in aged mice reflects both increased B cell longevity and decreased B cell generation. J Immunol 1999;162(6):3342–3349.
  • Gibson KL, Wu Y-C, Barnett Y, B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell 2009;8(1):18–25.
  • Colonna-Romano G, Bulati M, Aquino A, B cells in the aged: CD27, CD5, and CD40 expression. Mech Ageing Dev 2003;124(4):389–393.
  • Nossal GJ, Pike BL. Evidence for the clonal abortion theory of B-lymphocyte tolerance. J Exp Med 1975;141(4):904–917.
  • Cambier JC, Kettman JR, Vitetta ES, Uhr JW. Differential susceptibility of neonatal and adult murine spleen cells to in vitro induction of B-cell tolerance. J Exp Med 1976;144(1):293–297.
  • Metcalf ES, Klinman NR. In vitro tolerance induction of neonatal murine B cells. J Exp Med 1976;143(6):1327–1340.
  • Szewczuk MR, Siskind GW. Ontogeny of B-lymphocyte function. III. In vivo and in vitro studies on the ease of tolerance induction in B lymphocytes from fetal, neonatal, and adult mice. J Exp Med 1977;145(6):1590–1601.
  • LeGuern C. Potential role of major histocompatibility complex class II peptides in regulatory tolerance to vascularized grafts. Transplantation 2004;77(1 Suppl):S35–S37.
  • LeGuern C. Regulation of T-cell functions by MHC class II self-presentation. Trends Immunol 2003;24(12):633–638.
  • Benoist C, Mathis D. Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet. Annu Rev Immunol 1990;8:681–715.
  • Janick-Buckner D, Briggs CJ, Meyer TE, Major histocompatibility complex antigen expression on lymphocytes from aging strain A mice. Growth Dev Aging 1991;55(1):53–62.
  • Pietschmann P, Hahn P, Kudlacek S, Surface markers and transendothelial migration of dendritic cells from elderly subjects. Exp Gerontol 2000;35(2):213–224.
  • Herrero C, Sebastián C, Marqués L, Immunosenescence of macrophages: reduced MHC class II gene expression. Exp Gerontol 2002;37(2–3):389–394.
  • Dekruyff RH, Kann EA, Weksler ME, Siskind GW. Effect of aging on T-cell tolerance induction. Cell Immunol 1980;56(1):58–67.
  • Dobken J, Weksler ME, Sikind GW. Effect of age on ease of B-cell tolerance induction. Cell Immunol 1980;55(1):66–73.
  • Dejaco C, Duftner C, Schirmer M. Are regulatory T-cells linked with aging? Exp Gerontol 2006;41(4):339–345.
  • Qian T, Ricordi C, Inverardi L, Alejandro R. Intrathymic tolerance and age. Transplant Proc 1995;27(6):3391.
  • Nobori S, Shimizu A, Okumi M, Thymic rejuvenation and the induction of tolerance by adult thymic grafts. Proc Natl Acad Sci USA 2006;103(50):19081–19086.
  • Zhao L, Sun L, Wang H, Changes of CD4+CD25+Foxp3+ regulatory T cells in aged Balb/c mice. J Leukoc Biol 2007;81(6):1386–1394.
  • Sharma S, Dominguez AL, Lustgarten J. High accumulation of T regulatory cells prevents the activation of immune responses in aged animals. J Immunol 2006;177(12):8348–5835.
  • Trzonkowski P, Szmit E, Myśliwska J, Myśliwska A. CD4+CD25+ T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans-impact of immunosenescence. Clin Immunol 2006;119(3): 307–316.
  • Hausman PB, Goidl EA, Siskind GW, Weksler ME. Immunological studies of aging. XI. Age-related changes in idiotype repertoire of suppressor T cells stimulated during tolerance induction. J Immunol 1985;134(6):3802–3807.
  • Tsaknaridis L, Spencer L, Culbertson N, Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity. J Neurosci Res 2003;74(2):296–308.
  • Kozlowska E, Biernacka M, Ciechomska M, Drela N. Age-related changes in the occurrence and characteristics of thymic CD4+ CD25+ T cells in mice. Immunology 2007;122(3):445–453.
  • Nishioka T, Shimizu J, Iida R, CD4+CD25+Foxp3+ T cells and CD4+CD25-Foxp3+ T cells in aged mice. J Immunol 2006;176(11):6586–6593.
  • Wood KJ. Passenger leukocytes and microchimerism: what role in tolerance induction. Transplantation 2003;75(9):17S–20S.
  • Effros R. Costimulatory pathway in the elderly. Vaccine 2000;18(16):1661–1665.
  • Agrawal A, Agrawal S, Tay J, Gupta S. Biology of dendritic cells in aging. J Clin Immunol 2008;28(1):14–20.
  • Ordemann R, Hutchinson R, Friedman J, Enhanced allostimulatory activity of host presenting cells in old mice intensifies acute graft-versus-host disease. J Clin Invest 2002;109(9):1249–1256.
  • Castle CS, Uyemura K, Crawford W Antigen presenting cell function is enhanced in healthy elderly. Mech Ageing Dev 1999;107(2):137–145.
  • Sidman CL, Luther EA, Marschall JD, Increased expression of major histocompatibility complex antigens on lymphocytes from aged mice. Proc Natl Acad Sci USA 1997;84(21):7624–7628.
  • Della Bella S, Bierti L, Presicce P, Peripheral blood dendritic cells and monocytes are differently regulated in the elderly. Clin Immunol 2007;122(2):220–228.
  • Varas A, Sacedón R, Hernandez-López C, Age-dependent changes in thymic macrophages and dendritic cells. Microsc Res Tech 2003;62(6):501–507.
  • Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003;21:685–711.
  • Leng Q, Bentwich Z, Borkow G. CTLA-4 upregulation during age. Mech Ageing Dev 2002;123(10):1419–1421.
  • Azuma M, Phillips JH, Lanier LL. CD28-T lymphocytes: antigenic and functional properties. J Immunol 1993;150(4):1147–1459.
  • Lio D, D'Anna C, Gervasi F, Interleukin-12 release by mitogen-stimulated mononuclear cell in the elderly. Mech Ageing Dev 1998;102(2–3):211–219.
  • Fernandez-Gutierrez B, Jover JA, De Miguel S, Early lymphocyte activation in elderly humans: impaired T and T-dependent B cell responses. Exp Gerontol 1999;34(2):217–229.
  • Fox A, Harrison LC. Innate immunity and graft rejection. Immunol Rev 2000;173:141–147.
  • Palmer SM, Burch LH, Davis RD, The role of innate immunity in acute allograft rejection after lung transplantation. Am J Respir Crit Care Med 2003;168(6):628–632.
  • Obhrai J, Goldstein DR. The role of toll-like receptors in solid organ transplantation. Transplantation 2006;81(4):497–502.
  • Olszewski WL. Innate immunity processes in organ allografting—their contribution to acute and chronic rejection. Ann Transplant 2005;10(2):5–9.
  • Gomez CR, Boehmer ED, Kovacs EJ. The aging innate immune system. Curr Opin Immunol 2005;17(5):447–462.
  • LaRosa DF, Rahman AH, Turka LA. The innate immune system in allograft rejection and tolerance. J Immunol 2007;178(12):7503–7509.
  • Benichou G, Tonsho M, Tocco G, Innate immunity and resistance to tolerogenesis in allotransplantation. Front Immunol 2012;3:73.
  • Plackett TP, Boehmer ED, Faunce DE, Kovacs EJ. Aging and innate immune cells. J Leukoc Biol 2004;76(2):291–299.
  • Plowden J, Renshaw-Hoelscher M, Engleman C, Innate immunity in aging: impact on macrophage function. Aging Cell 2004;3(4):161–167.
  • Mishto M, Santoro A, Bellavista E, Immunoproteasomes and immunosenescence. Ageing Res Rev 2003;2(4):419–432.
  • Fulop T, Larbi A, Douziech N, Signal transduction and functional changes in neutrophils with aging. Aging Cell 2004;3(4):217–226.
  • Shaw AC, Panda A, Joshi SR, Dysregulation of human Toll-like receptor function in aging. Ageing Res Rev 2011;10(3):346–353.
  • Tesar BM, Du W, Shirali AC, Aging augments IL-17 T-cell alloimmune responses. Am J Transplant 2009;9(1):54–63.
  • De Martinis M, Modesti M, Loreto MF, Adhesion molecules on peripheral blood lymphocyte subpopulations in the elderly. Life Sci 2000;68(2):139–151.
  • d'Alessio P. Aging and the endothelium. Exp Gerontol 2004;39(2):165–171.
  • Hoffmann J, Haendeler J, Aicher A, Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ Res 2001;89(8):709–715.
  • Borrego F, Alonso MC, Galiani MD, NK phenotypic markers and IL2 response in NK cells from elderly people. Exp Gerontol 1999;34(2):253–265.
  • Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol Rev 1994;12:991–1045.
  • Park Y, Hirose R, Coatney JL, Ischemia-reperfusion injury is more severe in older versus young rat livers. J Surg Res 2007;137(1):96–102.
  • Okaya T, Blanchard J, Schuster R, Age-dependent responses to hepatic ischemia/reperfusion injury. Shock 2005;24(5):421–427.
  • Verbeke P, Fonager J, Clark BF, Rattan SI. Heat shock response and aging: mechanisms and applications. Cell Biol Int 2001;25(9):845–857.
  • Lee YK, Manalo D, Liu AK. Heat shock response, heat shock transcription factor and cell aging. Biol Signals 1996;5(3):180–191.
  • Aschcroft GS, Mills SJ, Ashworth JJ. Ageing and wound healing. Biogerontology 2002;3(6): 337–345.
  • Safirstein RL, Bonventre JV. Molecular response to ischemic and nephrotoxic acute renal failure. In: Molecular Nephrology: kidney function in health and disease. New York: Marcel Dekker; 1995: p. 839.
  • Megyesi J, Udvarhelyi N, Safirstein RL, Price PM. The p53-independent activation of transcription of p21 WAF1/CIP1/SDI1 after acute renal failure. Am J Pathol 1996;271(6):F1211–1216.
  • Franceschi C, Bonafe M, Valensin S, Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000;908:244–254.
  • Chelvarajan RL, Collins SM, Van Willigen JM, Bondada S. The unresponsiveness of aged mice to polysaccharide antigens is a result of a defect in macrophage function. J Leukoc Biol 2005;77(4): 503–512.
  • Gjertson DW. A multi-factor analysis of kidney graft outcomes at one and 5 years posttransplantation: 1996 UNOS update. Clin Transplant 1996;343:360.
  • Terasaki PI, Gertson DW, Cecka JM, Significance of the donor age effect on kidney transplants. Clin Transplant 1997;11:366–372.
  • Tullius SG, Tran H, Guleria I, The combination of donor and recipient age is critical in determining host immunoresponsiveness and renal transplant outcome. Ann Surg 2010;252(4): 662–674.
  • Meier-Kriesche HU, Cibrik DM, Ojo AO, Interaction between donor and recipient age in determining the risk of chronic renal allograft failure. J Am Soc Nephrol 2002;50(1):14–17.
  • Ojo AO, Wolfe RA, Held PJ, Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 1997;63(7):968–974.
  • Jassal SW, Olpez G, Cole E. Transplantation in the elderly: a review. Geriatr Nephrol Urol 1997;7(3):157–165.
  • Brandley BA. Rejection and recipient age. Transpl Immunol 2002;10(2–3):125–132.
  • Smits JM, Persijn GG, VanHouwelingen HC. Evaluation of the eurotransplant senior program. The results of the first year. Am J Transplant 2002;2(7):664–670.
  • Leichtman AB, McCullough KP, Wolfe RA. Improving the allocation system for deceased-donor kidneys. N Engl J Med 2011;364(14):1287–1289.
  • Meier-Kriesche HU, Ojo AO, Cibrik DM Relationship of recipient age and the development of chronic allograft failure. Transplantation 2000;70(2):306–310.
  • Sandman M, Bruunsgaard H, Kemp K, Is aging associated with a shift in the balance between type 1 and type 2 cytokines in humans? Clin Exp Immunol 2002;127(1):107–114.
  • Rea IM, McNerlan SE, Alexander HD. CD69, CD25, and HLA-DR activation antigen expression on CD3+ lymphocytes and relationship to serum TNF-alpha, IFN-gamma, and sIL-2R levels in aging. Exp Gerontol 1999;34(1):79–93.
  • Lou H, Kodama T, Zhao YJ Inhibition of transplant coronary arteriosclerosis in rabbits by chronic estradiol treatment is associated with abolition of MHC II antigen expression. Circulation 1996;94(12):3355–3361.
  • Weidmann P, Demyttenaere-Bursztein S, Maxwell MH, DeLima J. Effect of aging on plasma renin and aldosterone in normal man. Kidney Int 1975;8(5):325–333.
  • Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953;172(4279):603–606.
  • Martins PN. Impact of donor and recipient age on allograft tolerance. Exp Clin Transplant 2009;7(2):67–77.
  • Burnet FM. The clonal selection theory of acquired immunity. Nashville, TN: Vanderbilt University Press; 1959.
  • Vetro SW, Bellanti JA. Fetal and neonatal immunoincompetence. Fetal Ther 1989;4(Suppl 1): 82–91.
  • Streilein JW. Neonatal tolerance: towards an immunogenetic definition of self. Immunol Rev 1979;46:123–146.
  • White DJ, Gilks W. The ontogeny of immune responses. J Heart Lung Transplant 1993;12: S301–S308.
  • Ridge JP, Fuchs EJ, Matzinger P. Neonatal tolerance revisited: turning on newborn T-cells with dendritic cells. Science 1996;271(5256):1723–1726.
  • Ruiz P, Nassiri M, Gregorian S, Neonatal transplantation tolerance is associated with a systemic reduction in memory cells, altered chimeric cell phenotype, and modified ecosanoid and cytokine production. Transplantation 1996;61(8):1198–1205.
  • do Canto FB, Lima Junior C, Teixeira IA, Susceptibility of neonatal T cells and adult thymocytes to peripheral tolerance to allogeneic stimuli. Immunology 2008;125(3):387–396.
  • Hsu HC, Scott DK, Mountz JD. Impaired apoptosis and immune senescence—cause or effect? Immunol Rev 2005;205:130–146.
  • Prelog M. Aging of the immune system: a risk factor for autoimmunity? Autoimmun Rev 2006;5(2):136–139.
  • Urbán L, Bessenyei B, Márka M, Semsei I. On the role of aging in the etiology of autoimmunity. Gerontology 2002;48(3):179–184.
  • Habicht GS. Acquired immunological tolerance in aged mice. I. The dose–response relationship. Mech Ageing Dev 1982;19(1):53–62.
  • Ponnappan U, Cinader B, Gerber V, Blaser K. Age-dependent changes in isotype expression and down-regulation of C57BL/6 mice. Scand J Immunol 1987;25(1):45–54.
  • Staples PJ, Talal N. Relative inability to induce tolerance in adult NZB and NZB-NZWF1 mice. J Exp Med 1969;129(1):123–139.
  • Amagai T, Nakano K, Cinader B. Mechanisms involved in age-dependent decline of immune responsiveness and apparent resistance against tolerance induction in C57BL/6 mice. Scand J Immunol 1982;16(3):217–231.
  • de Faria AM, Ficker SM, Speziali E, Aging affects oral tolerance induction but not its maintenance in mice. Mech Ageing Dev 1998;102(1):67–80.
  • Wakabayashi A, Utsuyama M, Hosoda T, Differential age effect of oral administration of an antigen on antibody response: an induction of tolerance in young mice but enhancement of immune response in old mice. Mech Ageing Dev 1999;109(3):191–201.
  • Staples PJ, Steinberg AD, Talal N. Induction of immunologic tolerance in older New Zealand mice repopulated with young spleen, bone marrow, or thymus. J Exp Med 1970;131(6):1223–1238.
  • Vaz N, Faria MC, Verdolin A, Carvalho CR. Immaturity, ageing and oral tolerance. Scand J Immunol 1997;46:225–229.
  • Gahring LC, Weigle WO. The effect of aging on the induction of humoral and cellular immunity and tolerance in two long-lived mouse strains. Cell Immunol 1990;128(1):142–151.
  • Martins PN, Reutzel-Selke A, Jurisch A, Tullius SG. “Donor and recipient age prevent tolerance induction”. World Transplantation Congress (WTC). Am J Transplant 2006;6(Suppl 2):895.
  • Huang X, Sonawane S, Kim J, Age-dependent transplantation tolerance. Abstract 2513 WTC 2006. Am J Transplant 2006;6(Suppl 2):890.
  • Yamada K, Gianello PR, Ierino FL, Role of the thymus in transplantation tolerance in miniature swine: II. Effect of steroids and age on the induction of tolerance to class I mismatched renal allografts. Transplantation 1999;67(3):458–467.
  • Mackall CL, Gress RE. Thymic aging and T-cell regeneration. Immunol Rev. 1997;160:91–102.
  • Arlt W, Hewison M. Hormones and immune function: implications of aging. Aging Cell 2004;3(4):209–216.
  • Taub DD, Longo DL. Insights into thymic aging and regeneration. Immunol Rev 2005;205:72–93.
  • Fülöp T, Larbi A, Hirokawa K, Immunosupportive therapies in aging. Clin Interv Aging 2007;2(1):33–54.
  • Savino W, Postel-Vinay MC, Smaniotto S, Dardenne M. The thymus gland: a target organ for growth hormone. Scand J Immunol 2002;55(5):442–452.
  • De Mello-Coelho V, Savino W, Postel-Vinay MC, Dardenne M. Role of prolactin and growth hormone on thymus physiology. Dev Immunol 1998;6(3–4):317–323.
  • Dixit VD, Yang H, Sun Y, Ghrelin promotes thymopoiesis during aging. J Clin Invest 2007;117(10):2778–2790.
  • Bruinsma M, van Soest PL, Leenen PJ, Keratinocyte growth factor induces expansion of murine peripheral CD4+Foxp3+ regulatory T cells and increases their thymic output. J Immunol 2007;179(11):7424–7430.
  • Sportès C, Gress RE. Interleukin-7 immunotherapy. Adv Exp Med Biol 2007;601:321–333.
  • Henson SM, Pido-Lopez J, Aspinall R. Reversal of thymic atrophy. Exp Gerontol 2004;39(4):673–678.
  • Wils EJ, Cornelissen JJ. Thymopoiesis following allogeneic stem cell transplantation: new possibilities for improvement. Blood Rev 2005;19(2):89–98.
  • Haq AU. 1,25-Dihydroxyvitamin D3 (calcitriol) suppresses IL-2 induced murine thymocyte proliferation. Thymus 1986;8(5):295–306.
  • Vallabhajosyula P, Griesemer A, Yamada K, Vascularized composite islet-kidney transplantation in a miniature swine model. Cell Biochem Biophys 2007;48(2–3):201–207.
  • Bluestone JA. Regulatory T-cell therapy: is it ready for the clinic? Nat Rev Immunol 2005;5(4):343–349.
  • Bluestone JA, Thomson AW, Shevach EM, Weiner HL. What does the future hold for cell-based tolerogenic therapy? Nat Rev Immunol 2007;7(8):650–654.
  • Meyer JM, Archdeacon P, Albrecht R. FDA perspective: enrolment of elderly transplant recipients in clinical trials. Transplantation 2013;95(7):916–918.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.